A schizophrenia drug previously taken daily is now available as a once-monthly subcutaneous (SC) injection. On October 9, the ...

The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...

The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...

The FDA has approved Weltruza, the first once-monthly, subcutaneous, long-acting injectable form of olanzapine for adults ...

Enable Injections, Inc. (“Enable”), a leader in wearable drug delivery technologies, today announced the first regulatory approval of its enFuse ® On-Body Delivery System technology by Japan’s ...

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...

Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Subcutaneous mosunetuzumab replaced the IV infusion for patients with R/R LBCL; 57.5% had mostly mild injection-site ...

A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments. The idea for this so-called robotic pill came out of a research project around eight years ago from ...

Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. Seventy-three patients were given CdA as a subcutaneous injection once daily for 7 days. Complete remission (CR) ...